Articles from Biotech Business (September 1, 2005)

1-4 out of 4 article(s)

Title	Author	Type	Words
CYLENE INITIATES PHASE I CLINICAL TRIAL FOR CX-3543.			427
DOR BIOPHARMA/CAMBREX ACHIEVE RIVAX MILESTONE.			655
EXELIXIS INITIATES PHASE I CLINICAL TRIAL FOR ANTICANCER XL820.			644
MYOGEN COMPLETES ENROLLMENT FOR PHASE 3 ARIES-2 TRIAL.			828

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	before 1995 1995-1999 2000-2004 2005-2009 2010-	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z